Seaport Res Ptn Downgrades Aspen Aerogels (NYSE:ASPN) to Hold

Seaport Res Ptn lowered shares of Aspen Aerogels (NYSE:ASPNFree Report) from a strong-buy rating to a hold rating in a research report sent to investors on Wednesday morning,Zacks.com reports.

ASPN has been the subject of several other research reports. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Roth Mkm lowered their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Finally, Barclays lowered their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $24.67.

Read Our Latest Report on Aspen Aerogels

Aspen Aerogels Stock Down 3.7 %

ASPN stock opened at $8.67 on Wednesday. The stock has a market capitalization of $711.02 million, a P/E ratio of 867.47 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15. The firm has a 50-day moving average price of $12.27 and a 200-day moving average price of $18.56.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. As a group, equities research analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASPN. AlphaQuest LLC boosted its holdings in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after buying an additional 3,998 shares in the last quarter. nVerses Capital LLC boosted its holdings in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $164,000. Connors Investor Services Inc. bought a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $168,000. Finally, Journey Strategic Wealth LLC bought a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $178,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.